We are excited to announce the first ever Tell Series event giving a peek into the entrepreneurial world of biotech.

Dr. Aleš Štrancar, the founder of BIA Separations will share a story about his entrepreneurial journey of persistence and resilience that helped him launch the idea from Slovenia, a country in Central Europe, onto a global stage of world’s leading biopharmaceutical giants.

BIA Separations was established in Slovenia in 1998. It develops and manufactures products for purification and analysis of large biomolecules, such as viruses, plasmids and mRNA, which are destined for use in cell and gene therapies, as well as other advanced therapies. It is the inventor and exclusive producer of CIM (Convective Interaction Media) chromatographic columns for large biomolecules. With forecasted sales revenues of around €25m in 2020, BIA Separations was acquired by the German company Sartorius Stadium Biotech, in a deal worth € 360m in late 2020.

Aleš will take us on a journey from inception of the idea, through to development and commercialisation of the patented technology in BIA Separations that revolutionised manufacturing of advanced therapeutics globally. This is a story about lessons from personal and professional challenges Aleš had to endure on his entrepreneurial journey through failures to success, and his reflection on leading a company through growth and expansion that ultimately resulted in acquisition of BIA Separation by Sartorius in 2020.

Price

FREE of charge, however, you need to register below to attend.

Our events are often oversubscribed. Please cancel your ticket if you can no longer attend to give that opportunity to someone else.

When

25 May 2022

18:45 – Gates open

19:00 – Presentation by the founder - LT 1, Ratcliffe Building, Sussex

20:00 – Networking and Nibbles - Garden Room

Where

LT 1, Ratcliffe Building, Sussex, London Business School